The silent infection: should we be testing for perinatal hepatitis C and, if so, how?

Area of Science:

• Pediatric Infectious Diseases
• Hepatology
• Public Health Virology

Background:

• Hepatitis C virus (HCV) can be transmitted from mothers to infants during pregnancy or childbirth.
• Maternal HCV antibody positivity indicates a risk of vertical transmission to the neonate.
• Current screening guidelines for infants of HCV-positive mothers vary, necessitating clear recommendations.

Discussion:

• This study advocates for universal screening of all infants born to HCV antibody-positive mothers.
• Implementing routine infant screening can identify cases of vertical HCV transmission early.
• Early diagnosis facilitates prompt initiation of treatment and monitoring, potentially improving long-term outcomes.

Key Insights:

• Maternal HCV antibody status is a critical indicator for infant screening.
• Routine screening of newborns from HCV-positive mothers is a recommended public health strategy.
• Early identification of infant HCV infection is essential for effective management.

Outlook:

• Widespread adoption of this screening recommendation could reduce the burden of chronic HCV in the pediatric population.
• Further research may focus on optimizing screening protocols and evaluating the long-term impact of early treatment in infants.
• Enhanced surveillance and public health initiatives are needed to support infant HCV screening programs.